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ABSTRACT
Background: Clinical studies have shown that hippocampal atrophy is present before dementia in people with
memory deficits and can predict dementia development. The question remains whether this association holds
in the general population. This is of interest for the possible use of hippocampal atrophy to screen population
for preventive interventions. The aim of this study was to assess hippocampal volume and shape abnormalities
in elderly adults with memory deficits in a cross-sectional population-based study.
Methods: We included individuals participating in the Italian Project on the Epidemiology of Alzheimer
Disease (IPREA) study: 75 cognitively normal individuals (HC), 31 individuals with memory deficits (MEM),
and 31 individuals with memory deficits not otherwise specified (MEMnos). Hippocampal volumes and shape
were extracted through manual tracing and the growing and adaptive meshes (GAMEs) shape-modeling
algorithm. We investigated between-group differences in hippocampal volume and shape, and correlations
with memory deficits.
Results: In MEM participants, hippocampal volumes were significantly smaller than in HC and were
mildly associated with worse memory scores. Memory-associated shape changes mapped to the anterior
hippocampus. Shape-based analysis detected no significant difference betweenMEMandHC,whileMEMnos
showed shape changes in the posterior hippocampus compared with HC and MEM groups.
Conclusions: These findings support the discriminant validity of hippocampal volumetry as a biomarker of
memory impairment in the general population. The detection of shape changes in MEMnos but not in MEM
participants suggests that shape-based biomarkers might lack sensitivity to detect Alzheimer’s-like pathology
in the general population.
Key words: hippocampal atrophy, memory, MRI, population-based
Introduction
Alzheimer’s disease (AD) is a neurodegenerative
disease associated with the progressive accumula-
tion of neurofibrillary tangles and amyloid plaques
around neuronal cells, leading to neuronal loss,
cognitive deficits, and finally to clinically overt
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dementia (Selkoe, 2002). Despite considerable
efforts by the scientific community to unveil
the mechanisms behind AD, there is currently
no cure available for patients, and costs for
the management and care of the patients
are bound to rise considerably with increasing
life expectancy worldwide (http://www.alz.org/
downloads/facts_figures_2013.pdf). Currently, the
greatest hope for AD patients relies on early
therapeutic interventions aiming at delaying the
progression of the disease. Such measures are likely
to be more effective when administered during the
very early stages of the disease rather than to patients
with full blownAD (Emery, 2011). Indeed, delaying
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disease progression by one year in 2015 would
reduce the estimated prevalence by about 4 million
(8%) in 2050, which in turn would translate into
a considerable alleviation of the costs associated to
AD (Emery, 2011).
Important steps towards early AD detection have
been achieved in the past decade through the
development of in vivo biomarkers of pathology.
Among these, hippocampal atrophy is the
most established biomarker of neurodegeneration
(Bobinski et al., 2000) and is closely associated
with episodic memory deficits (Frisoni et al.,
2010). This well-established clinico-pathological
correlation motivated the inclusion of hippocampal
volume and medial temporal lobe (MTL) atrophy
as supportive features for AD diagnosis in the
newly published research criteria (Albert et al.,
2011). Imaging studies in individuals with mild
cognitive impairment (MCI), a population at
higher risk to develop AD (Petersen et al., 2001),
have shown that hippocampal volumes are already
reduced in these people (Jack et al., 2010).
Studies using an alternative definition of MCI (e.g.
aging-associated cognitive decline (AACD); Levy,
1994) similarly reported significant MTL atrophy
associated with cognitive deficits (Pantel et al.,
2003). More advanced hippocampal analysis tools,
such as shape-based methods, help to distinguish
between AD-related changes (affecting the anterior
dorsal CA1 field) and age-related changes (affecting
the ventral hippocampal head) (Apostolova et al.,
2006; Frisoni et al., 2008; Wang et al., 2003).
Overall, the discriminant and predictive validity of
hippocampal atrophy in clinical populations is good,
as demonstrated by studies rooted in a pattern
recognition framework (Apostolova et al., 2006;
Devanand et al., 2007; Clark et al., 2008; Colliot
et al., 2008; Karas et al., 2008; Klöppel et al., 2008;
Ferrarini et al., 2009).
Less known is whether hippocampal atrophy
can discriminate between normal cognition and
cognitive impairment in the general population.
This would be of interest for the possible use
of hippocampal atrophy to screen populations
for preventive interventions. The above-mentioned
studies were indeed based on clinical-based
populations, which typically include individuals at
a more advanced stage of cognitive impairment.
Conversely, population-based studies usually in-
clude patients in the earliest stages of the disease
and have thus a greater chance to detect subtle
changes associated with early cognitive impairment.
Population-based studies consistently showed that
hippocampal atrophy is associated with an increased
risk of dementia (see Table 1 for a summary
of population-based findings on hippocampal
atrophy, and Table S1, available as supplementary
material attached to the electronic version of this
paper at www.journals.cambridge.org/jid_IPG, for
a complete list of the main population-based
studies), supporting the validity of hippocampal
atrophy as a biomarker to predict conversion to
dementia. Conversely, there is mixed evidence on
the discriminant validity of hippocampal atrophy in
separating normal aging from people with cognitive
impairment (Table 1), thus limiting its potential
as a biomarker to screen at-risk populations.
Since hippocampal changes are likely to be subtle
in the earliest disease stages, finer approaches,
such as shape-based analysis methods, which have
the potential to detect very small morphological
changes, are needed. This study, therefore, aims at
assessing hippocampal shape and volume changes
in elderly people without dementia, drawn from
a population-based study carried out in Italy,
namely, the Italian PRoject on the Epidemiology of
Alzheimer disease (IPREA; Scafato et al., 2005).
Methods
Cohort
TOTAL IPREA SAMPLE
The participants included in this study were drawn
from the epidemiological IPREA study (Scafato
et al., 2005). The initial study included 2,985 Italian
elderly adults (aged between 65 and 84 years) who
underwent a personal and informant interview, a
physical and a neurological examination, and com-
prehensive neuropsychological testing, as described
in detail elsewhere (Scafato et al., 2010). A summary
of the diagnostic criteria used for participants
classification are reported in Appendix 2. Briefly,
the AACD criteria were used to classify patients
as cognitively normal (HC), patients with cognitive
impairment (AACD, AACD-nos, or objective
cognitive decline (OCD); see Appendix 2), and
patients with dementia (AD, vascular dementia
(VaD), Parkinson’s disease (PD) and other
dementias). Diagnosis of dementia was defined
based on internationally accepted criteria for the
various forms of dementia. In this population, it
has been estimated that the prevalence of cognitive
impairment is approximately 45% (9% fulfilling
AACD criteria, 19% fulfilling AACD-nos criteria,
and 17% fulfilling OCD criteria; Scafato et al.,
2010).
MRI SUBSTUDY
A subsample of the initial cohort underwent an
MRI scan (n = 567). The exclusion criterion for
MRI was diagnosis of dementia (Scafato et al.,
2005). Additionally, for the present study we
excluded participants with non-amnestic deficits
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Table 1. Literature review results: discriminant and predictive validity of hippocampal atrophy as a biomarker of cognitive impairment in
population-based studies
STUDY FOLLOW-UP SAMPLE HIPPOCAMPAL OUTCOME MAIN DISCRIMINANT PREDICTIVE
REFERENCEa DESIGN DURATION SIZE MEASURE MEASURES RESULTS VALIDITY VALIDITY
.....................................................................................................................................................................................................................................................................................................................................................................................................................................................
Wolf et al.
(2001)
Cross-
sectional
N.A. 17 controls
12 MCI
10 AD
HV (total,
head, body)
Group differences
Discrimination
accuracy
HV (total):
MCI < controls (11%–14% smaller)
AD < controls (26%–28% smaller)
AD < MCI;
HV (body): significantly different
over all three groups
Accuracy: 77% (HV for MCI vs.
controls)
Yes N.A.
Pantel et al.
(2003)
Cross-
sectional
N.A. 22 controls
21 AACD
12 AD
HV, PHV Group differences AACD < controls (PHV)
AD < AACD, controls (PHV, HV)
Yes/no N.A.
Pennanen
et al. (2004)
Cross-
sectional
N.A. 59 controls
65 MCI
HV Group differences
Discrimination
accuracy
MCI < controls (8% smaller)
Accuracy: 60%
Yes/no N.A.
Kumar et al.
(2006)
Cross-
sectional
N.A. 522 controls
29 MCI
HV Group differences
Prediction of
MCI
No group difference
Not a significant predictor
No N.A.
Scher et al.
(2007)
Cross-
sectional
N.A. 102 controls
24 incident
AD
HV, shape
analysis
Group differences HV: incident AD < controls (11%
smaller)
Shape: incident AD < controls
(lateral body: CA1, DG, subiculum)
Yes N.A.
Reitz et al.
(2009)
Cross-
sectional
N.A. 162 normal
22 naMCI
30 aMCI
17 adults
with
dementia
HV Group differences
Correlation
with memory
and language
Individuals with dementia < controls
Associated with word total recall in
the whole sample but not in normal
+ MCI or normal alone
No N.A.
Zhang et al.
(2011)
Cross-
sectional
N.A. 243 controls
146 MCI
(81 aMCI,
55 naMCI)
HV Prediction of
MCI, aMCI,
naMCI
Significant predictor of:
MCI (OR: 1.79)
aMCI (OR: 1.81)
naMCI (OR: 2.03)
Yes N.A.
Becker et al.
(2012)
Cross-
sectional
N.A. 29 normal
20 MCI
MTA, HV Group differences MCI < controls Yes N.A.
Cui et al.
(2012)
Cross-
sectional
N.A. 204 normal
79 aMCI
HV, subcortical
GM, CSF,
WM
Discriminating
features
Not a significant discriminator No N.A.
Zhang et al.
(2012)
Cross-
sectional
N.A. 120 controls
135 MCI
(74 aMCI,
61 naMCI)
VBM Group differences aMCI < controls Yes N.A.
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Table 1. Continued.
STUDY FOLLOW-UP SAMPLE HIPPOCAMPAL OUTCOME MAIN DISCRIMINANT PREDICTIVE
REFERENCEa DESIGN DURATION SIZE MEASURE MEASURES RESULTS VALIDITY VALIDITY
.....................................................................................................................................................................................................................................................................................................................................................................................................................................................
Visser et al.
(1999)
Longitudinal Three years
(clinical)
18 controls
20 MCI (9
converters, 4
stable)
7 AD
Baseline
MTA, HV,
PHV
Group differences
Correlation
with cognitive
decline
Prediction of
clinical
outcome
Baseline: AD < controls (MTA, PHV)
Follow-up: MCI converters < MCI
stable (PHV)
PHV correlated with memory
change
Significant predictors:
PHV (OR: 0.26 (0.08–0.86), 77%
accuracy)
HV (OR: 0.21 (0.05–0.99), 69%
accuracy)
MTA (OR: 12.2 (1.4–9.5), 77%
accuracy)
No Yes/no
Persson et al.
(2006)
Longitudinal Ten years
(clinical)
40 elderly:
20 with stable
memory
20 with
declining
memory
Baseline HV Group differences Declining < stable N.A. Yes
Herruka et al.
(2008)
Longitudinal Three to
five years
(clinical)
21 MCI:
13 stable
8 converters
Baseline HV Group differences
Correlation
with memory
Converters < stable
Word list delayed recall correlated
with HV in the whole sample and in
MCI-c
N.A. Yes
Tapiola et al.
(2008)
Longitudinal Three years
(clinical)
60 MCI:
47 stable
13 converters to
dementia
Baseline HV Group differences
Prediction of
conversion to
dementia
Converters < stable
Significant predictor of conversion
to dementia (HR > 0.73)
N.A. Yes
Godin et al.
(2010)
Longitudinal Four years
(clinical)
1,032 adults
without
dementia:
224 with
moderate
cognitive decline
46 with severe
cognitive decline
Baseline HV Prediction of
cognitive
decline
HV associated with increased risk of
moderate (OR: 0.7 (0.6–0.9)) and
severe cognitive decline (OR: 0.5
(0.3–0.7))
HV associated with annual changes
in memory and non-memory
N.A. Yes
den Heijer
et al.
(2010)
Longitudinal Eight years
(clinical
and
imaging)
518 adults without
dementia (50
converters to
dementia)
Baseline HV
Rate of HV
decline
Prediction of
conversion to
dementia
Baseline HV associated with risk of
dementia (HR > 2 (1.5–2.6))
Rate of HV decline associated with:
(i) risk of dementia (HR: 1.6
(1.2–2))
(ii) delayed memory decline in
dementia-free people (HR > 1.4
(1–2))
N.A. Yes
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and included all who had (i) normal cognition (HC)
or (ii) memory deficits (either AACD, AACD-
nos, or OCD). Memory deficits were assessed with
the Italian version of the Buschke Fuld Selective
Reminding Test (Spinnler and Tognoni, 1987),
which covers three aspects of episodic memory:
short-term recall (STR), long-term recall (LTR),
and long-term storage (LTS). Memory scores were
defined as abnormal when the score (adjusted for
age and education level using normative values for
the Italian population; Spinnler andTognoni, 1987)
was 1 SD below the mean for the population, as
suggested by Levy (1994).
Two hundred and six participants were excluded
due to incomplete or missing data (n = 170 due to
missing or incomplete clinical/neuropsychological
data; and n = 36 due to MRI artifacts precluding
hippocampal measurement), and 180 participants
were excluded because they did not fulfill the
clinical criteria (n = 179 showed cognitive deficits
in non-memory domains only; and n = 1 had
pseudo-dementia). A total of n = 181 participants
were eligible for the study, of whom 119 were
HC and 62 showed memory deficits. Of these, 19
participants had OCD, 12 fulfilled the criteria for
AACD, and the remaining 31 fulfilled the criteria
for AACD-nos (MEMnos). The OCD and AACD
groups were pooled together (MEM) since there
were no differences between the two groups in
terms of memory deficits. The MEM-nos group
was analyzed separately to distinguish pure memory
deficits (MEM) from deficits whichmight be related
to other not otherwise specified conditions (AACD-
nos criteria). Finally, since the initial HC sample
(n = 119) was slightly younger (age: 72 ± 4)
than the MEM and MEMnos groups (p < 0.001
on analysis of variance (ANOVA)), a subgroup of
HC was age-matched to the MEM and MEMnos
groups by selecting older controls (age > 70; n
= 75). Demographic data of the three groups are
shown in Table 2. Comparisons between the total
IPREA sample (n = 2,985) and the subsample
used for the present study (n = 137) are shown
in Table S2 (available as supplementary material
attached to the electronic version of this paper at
www.journals.cambridge.org/jid_IPG).
The design andmethodology of the IPREA study
have been approved by an international group of
experts (Scafato et al., 2005). The project has
been approved by the Ethics Committee of the
Istituto Superiore di Sanità (ISS). Written informed
consent was obtained from all the participants.
MRI acquisition and pre-processing
All the MRI scans were collected on the same
mobile Siemens Symphony 1 Tesla system between
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Table 2. Descriptive statistics for demographic data, memory scores, and hippocampal volumes
in the study cohort
HC MEM MEMNOS p
..................................................................................................................................................................................................................................................................................
N 75 31 31
Age 75 (3) 74 (5) 76 (5) 0.22
Gender (female) 35 (47%) 10 (32%) 13 (43%) 0.39
Education (years) 7 (3) 6 (2) 7 (4) 0.39
MMSE 28.1 (1.6) 26.9 (2.4)† 26.7 (3.1)∗ 0.006
Memory
STR 123 (26) 49 (12)° 50 (19)∗ <0.001
LTR 87 (44) 26 (18)° 24 (13)∗ <0.001
LTS 9 (2) 5 (1)° 5 (2)∗ <0.001
Volumetry
Left hippocampus (mm3) 3,740 (477) 3,449 (630)° 3,480 (530)† 0.011
Right hippocampus (mm3) 3,974 (449) 3,706 (638)° 3,730 (561)† 0.019
Values are mean (SD) or number (%); p denotes significance on the Analysis of Variance (ANOVA) for continuous
variables or the χ2 test for dichotomous variables.
°p < 0.05 in MEM versus HC (Bonferroni post hoc); ∗p < 0.05 in MEMnos versus HC (Bonferroni post hoc); †p < 0.10
(trend) in MEM versus HC or MEMnos versus HC (Bonferroni post hoc).
MEM = participants with memory deficits according to the AACD criteria; MEMnos = participants with memory
deficits not otherwise specified; HC = healthy controls; STR = short-term recall; LTR = long-term recall; LTS =
long-term storage.
March 2004 and May 2004. Quality control was
performed at each stopover using daily routine
procedures. High-resolution sagittal T1-weighted
gradient echo sequences were acquired using the
following parameters: TR = 11.4 ms, TE = 4.4 ms,
field of view= 250 mm, acquisition matrix= 256×
256, slice thickness = 1.3 mm, and flip angle =
80°.
Hippocampal volumetry
The three-dimensional (3D) images were processed
using a combination of scripts written in Perl
(http://www.perl.com), based on the Minc toolkit
developed at the McConnel Brain Imaging Centre
(Montreal Neurological Institute, McGill Uni-
versity, Montreal, Canada). Processing included
correction for magnetic field non-uniformities,
intensity normalization, and brain-to-brain linear
registration (9 degrees of freedom (dof)) to
a standard template in the stereotaxic space
(ICBM152) and re-sampling to an isotropic 1.5mm
voxel size. Each registered image was visually
compared to the template using Register (part of
Minc toolkit) and, when the automatic registration
failed (mainly due to high scalp brightness), a
manual registration was performed based on eleven
anatomical landmark points distributed over the
cerebrum and brainstem (the most anterior point
of the temporal poles, the most posterior aspect
on the occipital lobe, the most anterior point on
the frontal lobe, the central sulcus, the inferior
ventral aspect of the pons-midbrain cleft, the genu
and splenium of the corpus callosum, the inter-
thalamus adhesion, and the eyes). The hippocampi
were manually traced by a single expert tracer
with Display (part of Minc toolkit) on contiguous
coronal slices, simultaneously checking tracing
accuracy on the sagittal and axial planes. Tracings
included the hippocampus proper, dentate gyrus,
subiculum (subiculum proper and presubiculum),
alveus, and fimbria (Pruessner et al., 2000). Test-
retest reliability was assessed on 20 participants,
intraclass correlation coefficient being 0.93 for the
right and 0.94 for the left hippocampus.
To obtain the original hippocampal volumes (i.e.
in the native space), the brain with the traced
region of interest was back-transformed from the
stereotaxic to the native space. The accuracy of
the back-transformation was confirmed by visual
inspection. Hippocampal volumes were normalized
to intracranial volume to control for brain size
differences across the participants. Intracranial
volume was obtained with SIENAX (part of
FMRIB’s Software Library – FSL) by computing
the scaling factor mapping individual images to the
standard MNI152 template (Smith et al., 2002).
The reciprocal of this value was then computed to
obtain the intracranial volume.
Modeling of the hippocampal shape
The modeling of all hippocampal shapes was
performed using GAMEs (Ferrarini et al., 2007;
https://darwinnandoe.lumc.nl/drupal6/), a method
based on growing and adaptive meshes. GAMEs
has been successfully applied in several prior
studies, including investigation of shape changes
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in brain ventricles (Ferrarini et al., 2006; 2008),
basal ganglia structures (de Jong et al., 2011),
and hippocampi (Ferrarini et al., 2009). A detailed
description of the method can be found in Ferrarini
et al. (2007): briefly, a mesh is first grown (adding
nodes and edges) until convergence to a pre-defined
set of surface points (chosen as the average volume
of the HC group). Subsequently, the mesh topology
is frozen (number of nodes and edges), and only
the locations of nodes are allowed to adapt to
each individual set of hippocampal surface points.
The adaptation is performed applying the Kohonen
self-organizing map algorithm (Kohonen, 1990),
thus preserving topology. The set of final meshes
represents a point distribution model (PDM), in
which each node in a mesh is uniquely associated
to the anatomically equivalent nodes in all other
meshes. We applied GAMEs to the modeling of
both left and right hippocampi in the stereotaxic
ICBM152 space (see Figure S1(a), available as
supplementary material attached to the electronic
version of this paper at www.journals.cambridge.
org/jid_IPG). The modeling resulted in a total
of 137 meshes, one per participant, for each
hippocampus. The optimal number of nodes per
mesh was found to be 313, with each node locally
representing a surface area of approximately 2mm2.
This was chosen considering the resolution of
the data used to create the model (approximately
1.5 × 1.5 × 1.5 mm in standard space).
Choosing a higher accuracy for the mesh (i.e.
more nodes) would be meaningless, since it would
approach the limiting resolution of the original
data.
After having modeled each hippocampus, local
normal versors (i.e. vectors of length 1) were
identified along the surface model (see Figure
S1(b), available as supplementary material attached
to the electronic version of this paper at www.
journals.cambridge.org/jid_IPG). Subsequently, for
each given node and normal versor, all participants’
local node positions were projected along the
normal directions (see Figure S1(c), available as
supplementary material attached to the electronic
version of this paper at www.journals.cambridge.
org/jid_IPG): this resulted in a reduction of
dimensionality for the coding of each node across
the participants, from its original 3D coordinates
to a one-dimensional (1D) coordinate (i.e. its
projection along the local normal versor). Both
the 3D and 1D representations of nodes were
considered for subsequent analyses: specifically,
the 3D representation was used for the statistical
analysis of local shape differences between groups,
while the 1D representation was used for correlation
analysis of focal changes with memory scores and
age.
Statistical analysis
Statistical differences between groups in demo-
graphic, clinical, and volumetric features were
assessed with the ANOVA test (post hoc: Bonferroni
correction).
Second, focal morphological differences between
groups were analyzed. To this goal, a non-
parametric multidimensional test (Hotelling’s T2
test) was used. The statistical background has
already been provided in detail in previous works
(Ferrarini et al., 2006; 2007). In brief consider
a specific surface location (i.e. to specific node
in the mesh model): such a node is uniquely
associated to anatomically equivalent locations
across all participants and groups. Hence, focusing
on a given comparison (e.g. HC vs. MEM), two
clouds of 3D space locations can be identified. As
a first step, the Hotelling’s T2 statistic is evaluated.
Next, the association between node locations and
groups is permuted randomly for a given number
of times (i.e. 10,000). At each permutation, the
Hotelling’s T2 statistic is evaluated. Due to random
permutation, the set of statistics obtained in this
second phase follows the null hypothesis of no
difference between groups. Eventually, a p-value
for the original comparison (e.g. HC vs. MEM) is
obtained by considering the proportion of times in
which a higher statistics was obtained by chance
under the null-hypothesis (for more details about
non-parametric permutation tests, the reader is
referred to Appendix 3).
A correlation analysis was performed to
investigate the relationship between hippocampal
features (volumes and shape changes) and socio-
demographic and cognitive variables (age and
memory deficits) using the Pearson correlation
test. Correlations were performed separately for the
right and left hippocampi. For the morphological
features, the local 3D spatial information (node
locations across the participants) was first turned
into a 1D representation. The cognitive variables
were the STR, LTR, and LTS corrected scores. The
correlations were performed both across the entire
cohort (HC, MEM, and MEMnos) and separately
within each patient group (MEM and MEMnos).
The threshold for significance was set at p< 0.05 for
all the correlation analyses. Multiple comparisons’
correction was performed for volumetric data with
the False Discovery Rate procedure (Benjamini and
Yekutieli, 2001) at q = 0.10 and q = 0.05 levels.
For shape-based analysis, p-values were corrected
locally withHotelling’s T2 statistic and permutation
test (see previous paragraph).
Finally, the accuracy of hippocampal volumetry
in separatingMEMandMEMnos groups fromHC,
and participants with borderline cognition from
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controls, was estimated using receiver operating
characteristic (ROC) curves and computing the
corresponding area under the curve (AUC).
Results
Demographic and clinical data
No significant difference was detected across groups
for age, gender, and years of education (p >
0.22 on ANOVA; Table 2), which was in line
with the matching procedure. Memory scores
were significantly lower in MEM (p < 0.001 for
STR, LTR, and LTS; Bonferroni post hoc) and
MEMnos (p < 0.001) groups compared with HC,
in line with the selection criteria. Mini-Mental State
Examination (MMSE) was significantly lower in
MEMnos (p = 0.02 on Bonferroni) and showed
a trend for lower scores in MEM (p = 0.06 on
Bonferroni) participants compared with HC. No
significant differences were detected between the
MEM and the MEMnos groups in any of the
demographic and clinical variables (p > 0.05 on
Bonferroni post hoc).
Volumetric and morphological group
comparisons
Hippocampal volumes normalized to intracranial
volume differed significantly between groups (p <
0.02 on ANOVA; Table 2). Post hoc Bonferroni
showed that the left and right normalized
hippocampi were smaller in MEM compared with
HC (8% and 7% smaller for the left and right,
respectively; p = 0.03 for the left and p = 0.05 for
the right) and were marginally lower in MEMnos
compared with HC (p = 0.07 and p = 0.09).
Shape analysis showed no significant difference
between MEM and HC (p > 0.05 over the whole
hippocampal surface, data not shown). Conversely,
hippocampal shape differed significantly between
MEMnos and HC, significant differences mapping
to the posterior hippocampus (primarily the right
CA1 tail and the ventral subiculum bilaterally;
Figure 1, left panel). Direct comparisons between
MEM and MEMnos detected hippocampal
shrinkage in the latter group in the right CA1 tail
(Figure 1, right panel).
Volumetric correlation analysis
In the whole cohort, normalized hippocampal
volumes correlated significantly with age (r =
–0.21 and p = 0.01 for the left, and r = –
0.25 and p = 0.003 for the right hippocampus;
Table 3) and memory scores (p < 0.001 for all
memory variables; Table 3) and survived the false
discovery rate (FDR) correction (p < 0.033 at q
Figure 1. (Colour online) Signiﬁcant hippocampal shape differ-
ences between groups. The maps show signiﬁcant p-values
(p < 0.05, red to white colors) for the comparisons between HC
and MEMnos, and between MEM and MEMnos. No signiﬁcant
difference was detected between the MEM and HC groups (p >
0.05).
= 0.10 and p < 0.017 at q = 0.05). When the
analysis was restricted to patients with memory
deficits, a positive correlation was found in the
MEM group between the STR scores and the right
normalized hippocampal volume (r = 0.38, p =
0.04; Table 3) and the left normalized hippocampus
andLTS scores (r= 0.43, p= 0.04; Table 3). These
correlations survived FDR-correction at q = 0.10
(p < 0.042) but not at q = 0.05 (p < 0.021). No
significant correlation was found in the MEMnos
group (p > 0.05; Table 3).
Morphological correlation analysis
The results of morphological correlation analysis
are shown in color-coded hippocampal maps
representing the significance of the correlation (p-
values) and the corresponding signed R2 values
(Figures 2–4). These findings are described in detail
in the following sections.
WHOLE COHORT
Correlations between hippocampal shape changes
and STR and LTR memory deficits were localized
in the right CA1 tail and in the ventral subiculum
bilaterally (Figure 2(a)–2(b)). Long-term storage
memory scores were only weakly associated with
shape changes, mainly in the anterior ventral
hippocampus (subiculum, Figure 2(c)). Memory
scores were negatively correlated with atrophy (i.e.
lower memory scores corresponding to greater
atrophy). Age was positively correlated with atrophy
(i.e. lower ages corresponding to lower atrophy),
significant associations mapping to the anterior
hippocampus (head of the CA1 field and anterior
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Table 3. Correlations between hippocampal volumes, age, and memory deﬁcits
in the whole study sample, in the MEM sub-group, and in the MEMnos
sub-group
LEFT HIPPOCAMPUS RIGHT HIPPOCAMPUS
r p r p
....................................................................................................................................................................................................................................
Whole sample
Age − 0.21 0.01∗ − 0.25 0.003∗
STR 0.29 0.001∗ 0.33 <0.001∗
LTR 0.29 0.001∗ 0.32 <0.001∗
LTS 0.33 <0.001∗ 0.33 <0.001∗
MEM
Age − 0.27 0.15 − 0.29 0.11
STR 0.34 0.06 0.38 0.04∗
LTR 0.20 0.27 0.21 0.26
LTS 0.43 0.04∗ 0.35 0.09
MEMnos
Age − 0.22 0.24 − 0.34 0.06
STR 0.13 0.50 0.14 0.44
LTR 0.10 0.59 0.08 0.67
LTS 0.19 0.39 − 0.05 0.82
r denotes Pearson’s correlation coefficient; p denotes Pearson’s significance.
∗p < 0.05.
MEM = participants with memory deficits according to the AACD criteria; MEMnos = participants
with memory deficits not otherwise specified; STR = short-term recall; LTR = long-term recall;
LTS = long-term storage.
Figure 2. (Colour online) Correlations between local hippocampal changes and memory scores and age in the entire cohort. Maps show
signiﬁcant p-values (p< 0.05; red to white colors; left panel) and the corresponding R2 correlation values (positive correlations: orange-
to-red, negative correlations: green-to-blue; right panel).
ventral subiculum) bilaterally, and to the right
medial subiculum (Figure 2(d)).
MEM GROUP
When the analysis was restricted to the MEM
group, no correlation between atrophy and STR
and LTR scores was detected (Figure 3(a)–
3(b)). Conversely, LTS scores were significantly
correlated with hippocampal changes in the head
of the CA1 field (Figure 3(c)). The association
between age and shape changes in the anterior
hippocampus (head of the CA1 field and anterior
ventral subiculum) was still significant in this
subgroup (Figure 3(d)).
MEMNOS GROUP
Within the MEMnos group, no clear pattern of
correlation was observed between hippocampal
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Figure 3. (Colour online) Correlations between local hippocampal changes and memory scores and age in the MEM group. Maps show
signiﬁcant p-values (p< 0.05; red to white colors; left panel) and the corresponding R2 correlation values (positive correlations: orange
to red, negative correlations: green to blue; right panel).
Figure 4. (Colour online) Correlations between local hippocampal changes and memory scores and age in the MEMnos group. Maps
show signiﬁcant p-values (p < 0.05; red to white colors; left panel) and the corresponding R2 correlation values (positive correlations:
orange to red, negative correlations: green to blue; right panel).
shape and memory scores and age (Figure 4). Only
very small areas were detected which approached
non-significance (p = 0.05).
ROC analysis
Hippocampal volumes discriminated MEM from
HC with an accuracy of 0.63 and 0.66
for the left and right hippocampi respectively.
Similar values were obtained for the comparison
between MEMnos and HC (0.64 and 0.61).
When considering participants with borderline
deficits, hippocampal volumes showed chance-level
accuracy (0.54 and 0.60).
Discussion
The aim of this work was to investigate
the association between memory deficits and
hippocampal changes in a large population-based
elderly cohort. Participants were divided in three
groups: normal controls, MEM, and MEMnos. We
found that: (i) hippocampal volumes were smaller
in the MEM group compared with controls; (ii)
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hippocampal volumes correlated with long-term
memory deficits within the MEM group, significant
associations mapping to the anterior dorsal CA1
hippocampus.
These findings are consistent with previous
studies showing that hippocampal atrophy can
discriminate between normal aging and memory
impairment in the general population. A number
of previous studies failed to detect any difference
in hippocampal volumes between patients and
controls (see Table 1: Pantel et al., 2003; Kumar
et al., 2006; Reitz et al., 2009; Cui et al., 2012).
Others, conversely, reported significant volume
reductions, ranging between 7%–14% along the
spectrum from MCI to incident AD (see Table 1;
Wolf et al., 2001; Pennanen et al., 2004; Scher
et al., 2007; Zhang et al., 2011). Our study is in
agreement with the latter studies, as we observed
hippocampal volume reductions of 7%–8% in
participants with memory deficits, and overall,
supports the discriminant validity of hippocampal
volumetry in the general population. Some caution
is, however, warranted when generalizing these
results since hippocampal volumetry showed a
low accuracy in discriminating participants at the
individual level.
The observed correlations between hippocampal
atrophy and memory deficits are in line with
the known pathophysiology of memory decline in
patients with AD pathology. In the whole sample,
memory deficits were associated with hippocampal
reductions in regions that have been reported to
be specific to AD (dorsal head of the CA1 field;
Apostolova et al., 2006; Frisoni et al., 2008) but
also in regions non-uniquely associated to AD (CA1
tail and anterior ventral subiculum; Apostolova
et al., 2006; Frisoni et al., 2008). When the
analysis was restricted to the MEM group, the only
significant associations was in the CA1 dorsal head,
suggesting that the observed effects are specific
to patients with an AD-like profile. Although
some degree of overlap exists in the hippocampal
head between age- and memory-related patterns
(Frisoni et al., 2008), overall we observed only a
marginal overlap, mainly in the right dorsolateral
CA1 field. The hypothesis of an AD-like pattern
in the MEM group is further supported by the
observation that congruent memory-hippocampus
associations were observed in MEM but not
in MEMnos participants. Moreover, MEMnos
showed a hippocampal reduction of about 6%–
7% compared with controls, similarly to the MEM
participants, however, this reduction fell short of
statistical significance.
Shape-based analysis detected no significant
difference between MEM and HC, while MEMnos
showed shape changes in the posterior hippocampus
compared with HC and MEM groups. The lack
of significant shape changes in the MEM group is
unexpected, since shape-based analysis is expected
to detect very subtle and focal changes otherwise not
measurable with volumetry. A possible explanation
for this negative finding might be that the
hippocampus of our participants was affected by
small and generalized (rather than focal) reductions.
However, this explanation is unlikely since a large
amount of literature has previously shown that
atrophy affects specific hippocampal regions and
does not involve the whole hippocampus even in
full-blown AD (Wang et al., 2003; Apostolova et al.,
2006; Frisoni et al., 2008; Ferrarini et al., 2009).
An alternative explanation might be that shape-
based biomarkers are influenced to a greater extent
than volumetric measures by population variability,
a factor that might have reduced sensitivity to detect
group-differences in our sample. Since no previous
study has assessed shape changes in a population-
based sample, except for the study by Sher et al.
(2007), which, however, analyzed patients at a more
advanced disease stage (i.e. incident AD), future
studies are needed to clarify this issue.
The pattern of hippocampal changes in the
MEMnos group showed a good correspondence
with regions typically (albeit not specifically)
involved in AD, such as the tail of the
CA1 field and the posterior subiculum. On
the one hand, this result might indicate that
hippocampal changes in this subgroup are related
to a neurodegenerative process as well. On the
other hand, the pathophysiological mechanism
underlying these changes can hardly be ascribed to
AD pathology. Indeed, as we observed above, the
lack of an association between memory deficits and
morphological/volume changes in this group does
not support the view of an AD aetiology. Since these
participants represent a clinically heterogeneous
group, who did not fulfill the criteria for AACD
(due to the lack of evidence of a gradual onset
of cognitive deficits from at least six months, or
the past or current presence of medical/psychiatric
conditions or use of psychoactive substances), other
factors are likely responsible for the observed effect
in hippocampal morphology. Although we cannot
speculate on the possible mechanisms underlying
these abnormalities, it is likely that other factors
are involved, e.g. environmental or genetic factors,
as well as other pathologies. Since this pattern was
also observed in the comparison between MEMnos
and MEM, an alternative explanation might be
that these morphological changes simply represent a
specific feature of this heterogeneous sample. Not-
withstanding this uncertainty, we observe that volu-
metric and shape-based analysis was able to detect
significant differences between the two study groups
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in morphology and in cognitive-morphological
associations. This is encouraging in the perspective
of the use of hippocampal biomarkers for the
differential diagnosis and prediction of dementia.
Some limitations of the study ought to be
recognized. The relatively small size of the samples
might have introduced some bias. However,
although smaller than the original IPREA dataset,
our cohort was drawn from a representative
sample of the general elderly Italian population.
Another possible limitation is that we did not
collect biological markers of AD pathology, such
as amyloid levels on cerebrospinal fluid (CSF) or
amyloid positron emission tomography (PET), and
hypometabolism on fluorodeoxyglucose (FDG)-
PET (Albert et al., 2011). These examinations
indeed were not part of the original study protocol.
The IPREA study, however, is an ongoing project
and clinical follow-up will be collected for all the
participants. These data will indeed be used in
future studies to ascertain stability or conversion
of participants with memory deficits. Finally, no
phantomdata were collected to compareMRI signal
across sites. Notwithstanding this limitation, the
use of mobile MRI can offer some advantages
in the context of epidemiological studies. Mobile
MRI systems indeed enable: (i) to collect a large
number of MRI scans according to a tight schedule,
otherwise challenging for standard neuroradiology
units, and (ii) tomaximize comparability across sites
thanks to the use of fully harmonized machines and
protocol parameters.
In conclusion, shape and volume hippocampal
analysis showed that cognitive deficits are associated
with regionally specific hippocampal changes in
a population-based elderly cohort. Direct group
comparisons showed smaller hippocampal volumes
but failed to detect significant shape differences
between patients with pure memory deficits and
controls. Overall, these results are consistent with
the view that hippocampal changes occur early in
patients suspected to be at greater risk for AD.
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Appendix 2
Diagnostic and AACD criteria
Aging-associated cognitive decline criteria were developed
in 1994 to describe the transitional phase between normal
aging and dementia by the International Psychogeriatric
Association (IPA) in collaboration with the World Health
Organization (Levy, 1994). According to these criteria,
AACDdefinition is based on the results of a complete clinical
and neuropsychological assessment including (i) ADL and
IADL assessment (Lawton and Brody, 1969; Katz et al.,
1970), (ii) clinical dementia rating (CDR; Morris, 1993),
(iii)MMSE battery for global cognition (Measso et al., 1993;
Grigoletto et al., 1999), and (iv) neuropsychological tests for
the assessment of the major cognitive domains: (1) memory
and learning with the Buschke Fuld Selective Reminding
Test (Spinnler and Tognoni, 1987); (2) attention with the
Trail Making Test, A and B (Amodio et al., 2002); (3) verbal
ability with the Verbal Fluency Test for semantic categories
(Novelli et al., 1986); (4) visuoconstructive function with the
Constructional Praxis test (Spinnler and Tognoni, 1987);
and (5) problem-solving with the Raven colored progressive
matrices (Basso et al., 1987).
Based on this evaluation, the following diagnostic
categories were defined:
1. Participants were classified as cognitively normal if
they showed:
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(a) normal cognition on MMSE and neuropsycholo-
gical tests
(b) normal activities of daily living (ADL and IADL)
(c) CDR = 0
2. Participants were classified as AACD if they
showed:
(a) objective cognitive deficits in at least one cognitive
domain
(b) subjective gradual cognitive decline (reported by
the participant or an informant) present for at least
six months
(c) absence of any present or past medical/psychiatric
conditions or any psychoactive substances use that
could explain the cognitive deficits
(d) normal activities of daily living
(e) CDR = 0.5
3. Participants were classified as those with dementia
if they showed:
(a) abnormal neuropsychological tests
(b) abnormal activities of daily living
(c) CDR > 0.5
Additionally, the following three groups who did
not fulfill the above criteria were identified (Scafato
et al., 2010):
4. People with cognitive complaints (CC):
(a) normal cognition on MMSE and neuropsycholo-
gical tests
(b) cognitive complains by the subject and/or the
informant
(c) normal activities of daily living
(d) CDR = 0
5. People with objective evidence of cognitive decline
without cognitive complains (OCD):
(a) objective cognitive deficits in at least one cognitive
domain
(b) absence of cognitive complains (nor by the subject
nor by the informant)
(c) normal activities of daily living
(d) CDR = 0
6. People with AACD not otherwise specified
(AACD-nos, corresponding to the AACD-3 group
in the paper by Scafato et al., 2010). These
participants fulfilled three out of five criteria for
AACD (category 2). The criteria not met were the
second (gradual onset of symptoms) and the third
(absence of comorbidities).
For category 3 (people with dementia), a diagnosis of
dementia was defined based on international criteria for
the various forms of dementia: National Institute of
Neurological and Communicative Disorders and Stroke and
the Alzheimer’s Disease and Related Disorders Association
(NINCDS–ADRDA) criteria for AD (McKhann et al.,
1984); National Institute of Neurological Disorders and
Stroke and Association Internationale pour la Recherché
et l’Enseignement en Neurosciences (NINDS–AIREN)
criteria for VaD (Roman et al., 1993) and Erkinjuntti criteria
for subcortical VaD (Erkinjuntti et al., 2000); the McKhann
criteria for frontotemporal dementia (FTD) (McKhann
et al., 2001); the McKeith criteria for dementia with Lewy
bodies (DLB) (McKeith et al., 1996); and DSM-IV-TR
criteria for depressive pseudo-dementia, dementia associated
with Parkinson’s disease, medical conditions, and drug
abuse (American Psychiatric Association, 1994).
Appendix 3
Permutation test
Permutation tests have been successfully used for the
analysis of brain images (Nichols and Holmes, 2002;
Thompson et al., 2004): they require limited assumptions
and are corrected for multiple comparisons.
Given two populations G1 and G2, can we localize
statistically significant differences on the average surface?
The outcome of the permutation tests is, in the first place,
a p-value for the omnibus hypothesis the two groups G1
and G2 are drawn from the same population. Moreover, we
obtain the p-values for each node in the model, telling us
whether the distribution of that node in space is the same in
G1 and G2 or not. Since all meshes are co-registered to a
standard space, significant differences in space distribution
of a certain location indicates either a significant enlargement
or shrinking of one population with respect to the other
(hence pointing to atrophy).
Permutation tests can be summarized as follows:
1. considering two groups G1 and G2:
(a) for each node in the model, build up two clouds
of points, C1 and C2, considering the positions the
node assumes through all the shapes in G1 and G2;
(b) C1 and C2 are compared via a Hotelling’s T2
statistic test: outcome of the test is the t-value for
the node comparison (is the node distributed in
space in significantly different ways?); such a test
tests both the average positions in space for the two
clouds, and their variances.
2. for Nperm = 10,000 times, two groups of shapes A
and B are built up by randomly mixing G1 and G2,
and point 1 is performed on them. Only the highest
t-value is stored for each iteration;
3. a critical t-value tc is evaluated as the kth high-
est value of all the Nperm t-values previously stored
(plus the tMax for the original division in G1–G2),
where
k = α × Nperm c + 1, α = 0.05 (1)
4. the p-value for the omnibus hypothesis “G1 and G2
are the same” is evaluated as
pvalue = N/Ntests , where (2)
N = #{stored tvalues |tvalues > tc}, (3)
Ntests = Nperm + 1; (4)
5. finally, point 4 is applied to each single node,
counting how many t-values are higher than the
t-value associated with a particular node in the
original G1–G2 grouping of shapes, and dividing
the number for Nperm + 1; this leads to a p-value
(corrected for multi-tests) for each node in the
model.
https:/www.cambridge.org/core/terms. https://doi.org/10.1017/S1041610213002627
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 30 May 2017 at 18:53:24, subject to the Cambridge Core terms of use, available at
